Category: Health Policy

Guest blog: the Change Challenge Collaborative

by Greta McLachlan, Fellow at the Strategic planning and development cell, NHS England and Improvement, part of the Change Challenge Collaborative.

The change challenge collaborative is a group of professionals who have come together to work across the MSK, orthopaedic and rheumatology specialties to try and capture beneficial changes that have occurred within the NHS during COVID- 19. The aim being to try and capture these changes and ideas to ensure that these innovations are not lost when the NHS comes out of its pandemic measures.…

Read more of this article

NICE publishes new guidelines on elective surgery, planned care

A new COVID-19 rapid guideline: arranging planned care in hospitals and diagnostic services NICE guideline [NG179] has been released by NICE. The publication makes recommendations for how these services should be organised to balance the risks associated with covid-19 and the potential harms that could arise from delays in elective treatment and diagnostic procedures.

The guidance states that people having planned care involving any form of anaesthesia and sedation should follow social distancing and hand hygiene measures for 14 days prior to admission – a change from 14 days of self-isolation.…

Read more of this article

BOA Policy update – July 2020

report coverThe report emergent from Baroness Cumberlege and the Independent Medicines and Medical Devices Safety review was published in early July and has been welcomed by the British Orthopaedic Association. This comprehensive review has demonstrated the impact on the physical and mental health of patients when implants fail. The review shows that there is a clear need for detailed surveillance of implants, and we welcome the recommendation for the establishment of more National Implant Registries.

Read the BOA’s full position on this issue.…

Read more of this article

New guidance on corticosteroids

The guidance ‘Management of Patients with Musculoskeletal and Rheumatic Conditions on Corticosteroids’ has now been superseded by the following guidance, issued on 16 June 2020. It applies to:

Management of patients with musculoskeletal and rheumatic conditions who:

  • – are on corticosteroids
  • – require initiation of oral/IV corticosteroids
  • – require a corticosteroid injection

The new guidance can be read here [open PDF].

SOMM’s Injection Module Coordinator, Paul Hattam, has submitted his view on the guidance for corticosteroid injection that has been provided throughout the COVID-19 pandemic, as an open letter to the CSP’s ‘Frontline’ magazine.…

Read more of this article

The changing landscape of orthopaedic services in light of the COVID-19 pandemic

Guest blog by

Cormac Kelly, Consultant Upper Limb Surgeon at The Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust

and

Peter Kay, National Orthopaedic Alliance (NOA) Lead Clinician and Consultant Orthopaedic Surgeon at Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust

The COVID-19 crisis has changed the delivery of planned orthopaedic surgery drastically. As the pandemic continues to subside, the NHS, with various guidance from Public Health England, Medical and Surgical Colleges, the British Orthopaedic Association, and others, is working on a plan to get surgery back on track.…

Read more of this article

Guest blog: MSK First Contact Practitioner roles

MSK First Contact Practitioner roles; are they fit for the future for Primary Care?

by
Amanda Hensman-Crook FCSP, HEE AHP National Clinical Fellow, Consultant MSK Physiotherapist
Neil Langridge FCSP, Consultant MSK Physiotherapist
Laura Finucane FCSP, MSK Consultant MSK Physiotherapist
Chris Mercer FCSP, MSK Consultant MSK Physiotherapist

MSK First Contact Practitioner roles and the advancing practice agenda is moving at pace and as a result, there has been some anxiety around the MSK First Contact workforce. This has been expressed about several aspects of the roles, including:

  • numbers needed to ensure sustainability without wider destabilisation of the MSK workforce
  • where the workforce will come from with the requisite capability
  • concern about governance of the roles
  • who provides the supervision and support
  • a general need to understand the offer of the role to primary care
  • concern from other MSK professions that they are not included in the GP contract reimbursement scheme (DES) and where they might fit in the bigger picture.
…

Read more of this article

Health Equity in England: The Marmot Review 10 Years On

We know that musculoskeletal conditions are much more prevalent in deprived areas so the publication of this report is very relevant to addressing the social determinants of MSK health. It has been produced by the Institute of Health Equity and commissioned by the Health Foundation to mark 10 years on from the landmark study Fair Society, Healthy Lives (The Marmot Review).

The report highlights that:

  • people can expect to spend more of their lives in poor health
  • improvements to life expectancy have stalled, and declined for the poorest 10% of women
  • the health gap has grown between wealthy and deprived areas
  • place matters – living in a deprived area of the North East is worse for your health than living in a similarly deprived area in London, to the extent that life expectancy is nearly five years less.
…

Read more of this article

Postcode lotteries and transformations

by Sue Brown, ARMA CEO

February has been a month of mixed feelings for me. On the downside I continue to hear of rationing of NHS services by CCGs going against NICE guidelines. More positively I’ve been hearing about some ambitious work to transform MSK services around the country. We need some of this bold thinking if we are going to achieve ARMA’s goal of high quality, appropriate MSK services for everyone who needs them.

This month I spoke to someone in a hospital about hip and knee replacement.…

Read more of this article